Share Prices & Company Research

Stockbroking

Biopharma Credit Plc

Current Price 88.00p Bid 84.60p Ask 94.00p Change 0.00%
Last Updated: 09/05/2024 08:17. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

BioPharma Credit plc provides investors with an opportunity to gain exposure to the fast growing life sciences industry, through a diversified portfolio of loans and other instruments backed by royalties or other cash flows derived from sales of approved life sciences products. BioPharma Credit's primary objective is to generate predictable income for shareholders over the long term.

Financial Highlights Year Ended 31/12/2019

Revenue
£n/am
Operating Profit/Loss
£113.82m
Dividend yield (%)
6.90
Total dividend for year
$0.0828
Dividend cover
1.18
P/E Ratio
12.30
More Financials

Key Personnel

Mr Colin Bond
Director
Mr Duncan W A Budge
Director
Mr Harry Abraham Hyman
Director
Ms Stephanie Léouzon
Non-Executive Director

Stock Details

EPIC
BPCRL
ISIN
GB00BDGKMY29
Shares in Issue
0.00m
Market cap
£0.00m

Analyst Views (0)

Strong Buy
 
0%
Buy
 
0%
Hold
 
0%
Sell
 
0%
Strong Sell
 
0%
This information is provided by Web Financial Group (UK) Limited. It is subject to change without notice and doesn't reflect the views held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
88.00p
Bid Price
84.60p
Ask Price
94.00p
Volume
60,492
Change Today
0.00p
% Change Today
0.00%
Open
88.40p
Previous Close
88.00p
Intraday High
89.30p
Intraday Low
88.00p
52 Week High
96.00p
52 Week Low
81.80p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

More Charts

News

Income Statement

Year End Date
31 Dec 2019
31 Dec 2018
 
$ (M)
$ (M)
Continuing Operations
Revenue
n/a
n/a
Operating Profit/Loss
113.82
73.63
Net Interest
n/a
n/a
Pre-Tax Profit
113.82
69.95
Profit After Tax from continuing operations
113.82
69.95
Discontinued Operations
Profit After Tax
n/a
n/a
Profit/Loss for the Year
n/a
n/a
Attributable to:
Equity Holders of Parent Company
n/a
n/a
Minority Interests
n/a
n/a
Total Dividend Paid
$0.0828
$0.0677
Retained Profit/(Loss) for the Financial Year
113.82
69.95

Earnings per Share

Year End Date
31 Dec 2019
31 Dec 2018
Basic
8.28c
7.07c
Diluted
8.28c
7.07c
Adjusted
8.28c
7.07c
Dividend per Share
$0.0828
$0.0677

Assets

Year End Date
31 Dec 2019
31 Dec 2018
 
$ (M)
$ (M)
Non-Current Assets
Property, Plant & Equipment
n/a
n/a
Intangible Assets
n/a
n/a
Investment Properties
n/a
n/a
Investments
n/a
n/a
Other Financial Assets
n/a
n/a
Other Non-Current Assets
n/a
n/a
Current Assets
Inventories
n/a
n/a
Trade & Other Receivables
n/a
n/a
Cash at Bank & In Hand
296.64
363.57
Current Asset Investments
n/a
n/a
Other Current Assets
n/a
n/a
Other Assets
n/a
n/a
Total Assets
1,428.97
1,393.27

Liabilities

Year End Date
31 Dec 2019
31 Dec 2018
 
$ (M)
$ (M)
Current Liabilities
Borrowings
n/a
n/a
Other Current Liabilities
n/a
n/a
Total Current Liabilities
n/a
n/a
Non-Current Liabilities
Borrowings
n/a
n/a
Provisions
n/a
n/a
Other Non-Current Liabilities
n/a
n/a
Total Non-Current Liabilities
n/a
n/a
Other Liabilities
n/a
n/a
Total Liabilities
25.23
13.25

Net Assets

Year End Date
31 Dec 2019
31 Dec 2018
 
$ (M)
$ (M)
Net Assets
1,403.74
1,380.02

Capital & Reserves

Year End Date
31 Dec 2019
31 Dec 2018
 
$ (M)
$ (M)
Share Capital
n/a
n/a
Share Premium Account
607.12
607.12
Other Reserves
741.18
736.35
Retained Earnings
n/a
n/a
Shareholders Funds
1,403.74
1,380.02
Minority Interests/Other Equity
n/a
n/a
Total Equity
n/a
n/a

Dividend History

Type
Ex-Dividend Date
Payment Date
Payment
1st Interim
28 Mar 2024
30 Apr 2024
1.75¢
Special
15 Feb 2024
15 Mar 2024
1.21¢
Special
15 Feb 2024
15 Mar 2024
1.21¢
Special
07 Dec 2023
05 Jan 2024
2.00¢
Special
07 Dec 2023
05 Jan 2024
2.00¢
2nd Interim
17 Aug 2023
15 Sep 2023
1.75¢
1st Interim
27 Apr 2023
26 May 2023
1.75¢
Special
30 Mar 2023
28 Apr 2023
1.58¢
Special
30 Mar 2023
28 Apr 2023
1.58¢
Special
20 Oct 2022
18 Nov 2022
4.50¢
Special
20 Oct 2022
18 Nov 2022
0.045¢
2nd Interim
25 Aug 2022
23 Sep 2022
1.75¢
1st Interim
05 May 2022
31 May 2022
1.75¢
4th Interim
03 Mar 2022
31 Mar 2022
1.75¢
3rd Interim
18 Nov 2021
17 Dec 2021
1.75¢
2nd Interim
19 Aug 2021
17 Sep 2021
1.75¢
1st Interim
03 Jun 2021
30 Jun 2021
1.75¢
Special
18 Mar 2021
16 Apr 2021
0.2901¢
Special
19 Nov 2020
18 Dec 2020
0.01¢
3rd Interim
19 Nov 2020
18 Dec 2020
1.75¢
Special
19 Nov 2020
18 Dec 2020
0.01¢
2nd Interim
20 Aug 2020
18 Sep 2020
1.75¢
1st Interim
21 May 2020
19 Jun 2020
1.75¢
4th Interim
27 Feb 2020
27 Mar 2020
1.75¢
Special
27 Feb 2020
27 Mar 2020
1.28¢
3rd Interim
14 Nov 2019
17 Dec 2019
1.75¢
2nd Interim
15 Aug 2019
20 Sep 2019
1.75¢
1st Interim
23 May 2019
21 Jun 2019
1.75¢
Special
28 Feb 2019
29 Mar 2019
0.17744¢
Special
28 Feb 2019
29 Mar 2019
0.17744¢
3rd Interim
01 Nov 2018
30 Nov 2018
1.75¢
2nd Interim
30 Aug 2018
28 Sep 2018
1.75¢
1st Interim
31 May 2018
29 Jun 2018
1.34¢
Special
08 Mar 2018
29 Mar 2018
1.10¢
Special
08 Mar 2018
29 Mar 2018
1.10¢
2nd Interim
14 Dec 2017
31 Jan 2018
1.00¢
1st Interim
28 Sep 2017
31 Oct 2017
1.00¢

Dividend Metrics

Year End Date
31 Dec 2019
31 Dec 2018
Dividend growth
0.86%
131.33%
Dividend yield
6.90%
6.50%
Dividend cover
1.18
1.02


Cboe Global Markets® is a registered trade mark of Cboe Global Markets, Inc., a company incorporated in the United States of America with registered address at 400 South LaSalle Street, Chicago, IL 60605, USA. Cboe shall own any and all rights including without limitation Intellectual Property rights and any and all goodwill arising directly or indirectly out of the Recipient’s use of the “Cboe Global Markets®”, “Cboe®” and “Bats®”” trademarks. Neither Cboe nor its licensors accept any liability for any errors or omissions in the Cboe Europe Indices or underlying data. No further distribution of Cboe Europe data is permitted without Cboe’s express written consent.

The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.